angela mastronuzzi
Bambino GesĂą Children's Hospital (IRCCS)
Rome, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Bambino GesĂą Children's Hospital (IRCCS)
Rome, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
INSERM U970 Paris Centre de Recherche Cardiovasculaire (PARCC)
Paris, France
Review Editor
Cancer Molecular Targets and Therapeutics
Polytechnic Institute of Lusophony
Lisbon, Portugal
Review Editor
Cancer Molecular Targets and Therapeutics
Department of Oncology, Wroclaw Medical University
Wrocław, Poland
Review Editor
Cancer Molecular Targets and Therapeutics
Department of Clinical and Experimental Medicine, University of Pisa
Pisa, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Indiana University, Purdue University Indianapolis
Indianapolis, United States
Review Editor
Cancer Molecular Targets and Therapeutics
British Columbia Cancer Agency
Vancouver, Canada
Review Editor
Cancer Molecular Targets and Therapeutics
University of Alabama at Birmingham
Birmingham, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Department of Medical oncology, Siena University Hospital
Siena, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Medical University of Gdansk
Gdańsk, Poland
Review Editor
Cancer Molecular Targets and Therapeutics
Hospital Universitario FundaciĂłn AlcorcĂłn
AlcorcĂłn, Spain
Review Editor
Cancer Molecular Targets and Therapeutics
Consorzio per Valutazioni Biologiche e Farmacologiche
Pavia, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Foro Italico University of Rome
Rome, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
University of Bergen
Bergen, Norway
Review Editor
Cancer Molecular Targets and Therapeutics
University of Pisa
Pisa, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Vall d'Hebron University Hospital
Barcelona, Spain
Review Editor
Cancer Molecular Targets and Therapeutics